With reference to letter dated October 27, 2017 for intimation of Board Meeting scheduled to be held on November 9, 2017 to consider the unaudited financial results of the Company for the quarter ended September 30, 2017, Sequent Scientific has informed that the Board of Directors shall also consider the declaration of Interim dividend, if any, for the financial year 2017-18, at the aforesaid Meeting.
The above information is a part of company’s filings submitted to BSE.